South & Central America Coagulation Market Forecast to 2030
South & Central America Coagulation Market Forecast to 2030 – Regional Analysis – by Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand’s Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), and End User (Clinical Laboratories, Hospitals, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Growing Organic and Inorganic Strategies by Key Market Players Fuel South & Central America Coagulation Market
Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.
– In June 2021, Trivitron Healthcare introduced NANO H5 and NANO H110, which help in monitoring diabetes, hemoglobin variations, and thalassemia.
– In February 2021, Siemens Healthineers and Sysmex Corporation renewed their agreement to supply, distribute, sell, and service hemostasis products across the world. The agreement also included an extension for multiple years. Further, Siemens Healthineers agreed to distribute Sysmex’s automated blood coagulation analyzer, such as the CN-3000 and CN-6000.
– In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a range of convenient ready-to-use reagents for common blood coagulation Offerings. With this expansion of its product line, HORIBA Medical now offers a comprehensive selection of hemostasis systems and advanced reagents for laboratories of all sizes and requirements.
Thus, the adoption of various organic and inorganic strategies by the key market players is expected to provide opportunities for the coagulation market growth during the forecast period.
South & Central America Coagulation Market Overview
The South & Central America coagulation market is segmented into Brazil, Argentina, and the Rest of South & Central America. The factors that are likely to contribute to the market growth in this region include government initiatives to expand the healthcare infrastructure and a surge in the population with various chronic diseases such as liver diseases and hemophilia.
Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia are among the major countries in the Rest of South & Central America. The countries are strengthening their healthcare infrastructure by allowing new market participants to enter the market. Furthermore, governments of these countries are showing interest and spending significantly on upgrading their healthcare services, which has triggered the number of health facilities in these countries. Moreover, a rise in the geriatric population, coupled with the burgeoning prevalence of blood disorders, cardiovascular diseases, liver diseases, etc., highlights the importance of precise blood component analysis, which fuels the growth of the coagulation market in the Rest of South & Central America.
South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Coagulation Market Segmentation
The South & Central America coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.
Based on disease indication, the South & Central America coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand’s disease, and others. The liver disease segment held the largest South & Central America coagulation market share in 2022.
Based on type, the South & Central America coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger South & Central America coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.
In terms of offering, the South & Central America coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger South & Central America coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.
By technology, the South & Central America coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest South & Central America coagulation market share in 2022.
By end user, the South & Central America coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held the largest South & Central America coagulation market share in 2022.
Based on country, the South & Central America coagulation market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America coagulation market in 2022.
F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Horiba Ltd; ImproGen Diagnostik Kimya San & Tic Ltd.Şti.; Siemens Healthineers AG; Sysmex Corp; and Transasia Bio-Medicals Ltd are some of the leading companies operating in the South & Central America coagulation market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the South & Central America coagulation market was valued at US$ 401.01 million in 2022 and is expected to reach US$ 700.04 million by 2030, registering a CAGR of 7.2% from 2022 to 2030. Development of point-of-care (POC) coagulation analyzers and increasing prevalence of blood disorders are among the critical factors attributed to the South & Central America coagulation market expansion.
A rapid, reliable assessment of hemostasis is essential for patients suffering from trauma or other bleeding problems. Due to the constraints of sample preparation and analytical process, routine coagulation assays cannot analyze clot formation, and their results can be obtained only after 30-90 minutes. POC devices such as platelet function test, viscoelastic coagulation tests, blood gas analysis, and other coagulometers are available for assessment of hemostasis. A POC measurement tool can be used inside and outside the hospital as a decision-making and management tool. When time is paramount, POC analyzers provide immediate, actionable results in emergency rooms, coronary care units, surgery, and procedure suites. In addition to outpatient clinics and physicians’ offices, these devices can assist in patient management in pharmacies, care centers, and patients’ homes. POC coagulation analyzers offer timely results without compromising diagnostic quality control provided by central labs. In POC testing, it is important to provide fast results, along with accuracy and quality assurance.
In 2021, Siemens Healthineers launched fully automated CN-3000 and CN-6000 systems, which are mid- and high-volume handheld POC coagulation testing devices. The FDA cleared Siemens Healthineers’ Xprecia Stride Coagulation Analyser in 2016, as a POC coagulation analyzer device. The device has demonstrated prothrombin time/international normalized ratio (PT/INR) testing performance equivalence to Roche CoaguChek XS.
Thus, the growing developments in POC coagulation analyzers are expected to boost the coagulation market growth during the forecast period.
On the contrary, high costs associated with coagulation analyzers hampers the growth South & Central America coagulation market.
Based on disease indication, the South & Central America coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand’s disease, and others. The liver disease segment held 53.3% share of the South & Central America coagulation market in 2022, amassing US$ 213.64 million. It is projected to garner US$ 367.93 million by 2030 to expand at 7.0% CAGR during 2022-2030.
Based on type, the South & Central America coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held 61.4% share of the South & Central America coagulation market in 2022, amassing US$ 246.41 million. It is projected to garner US$ 407.63 million by 2030 to expand at 6.5% CAGR during 2022-2030. Clinical laboratory analysers is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.
In terms of offering, the South & Central America coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held 64.1% share of the South & Central America coagulation market in 2022, amassing US$ 256.98 million. It is projected to garner US$ 443.03 million by 2030 to expand at 7.0% CAGR during 2022-2030. Diagnosis is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.
By technology, the South & Central America coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held 61.4% share of South & Central America coagulation market in 2022, amassing US$ 246.07 million. It is projected to garner US$ 433.78 million by 2030 to expand at 7.3% CAGR during 2022-2030.
By end user, the South & Central America coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held 61.5% share of South & Central America coagulation market in 2022, amassing US$ 246.46 million. It is projected to garner US$ 436.30 million by 2030 to expand at 7.4% CAGR during 2022-2030.
Based on country, the South & Central America coagulation market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil held 33.7% share of South & Central America coagulation market in 2022, amassing US$ 135.02 million. It is projected to garner US$ 241.86 million by 2030 to expand at 7.6% CAGR during 2022-2030.
Key players operating in the South & Central America coagulation market are F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Horiba Ltd; ImproGen Diagnostik Kimya San & Tic Ltd.Şti.; Siemens Healthineers AG; Sysmex Corp; and Transasia Bio-Medicals Ltd, among others.
In Feb 2021, Siemens Healthineers and Sysmex Extend Hemostasis Agreement. Siemens Healthineers and Sysmex Corporation announced the renewal of the companies’ long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis products including a multi-year extension. As part of the agreement Siemens Healthineers will distribute the new Sysmex CN Systems.
In Aug 2021, Siemens Healthineers Launched Sysmex CN-3000 and CN-6000 Hemostasis Systems. This fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America coagulation market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the coagulation market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Coagulation Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Increasing Prevalence of Blood Disorders
4.1.2 Rising Prevalence of Cardiovascular Diseases
4.2 Market Restraints
4.2.1 High Costs Associated with Coagulation Analyzers
4.3 Market Opportunities
4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
4.4 Future Trends
4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
4.5 Impact Analysis
5. Coagulation Market – South & Central America Market Analysis
5.1 South & Central America Coagulation Market Revenue (US$ million), 2022 – 2030
6. South & Central America Coagulation Market – Revenue and Forecast to 2030 – by Disease Indication
6.1 Overview
6.2 South & Central America Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
6.3 Vitamin K Deficiency
6.3.1 Overview
6.3.2 Vitamin K Deficiency: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Liver Disease
6.4.1 Overview
6.4.2 Liver Disease: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
6.5.1 Overview
6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Development of Circulating Anticoagulant
6.6.1 Overview
6.6.2 Development of Circulating Anticoagulant: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.7 Hemophilia
6.7.1 Overview
6.7.2 Hemophilia: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.8 Von Willebrand’s Disease
6.8.1 Overview
6.8.2 Von Willebrand’s Disease: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.9 Others
6.9.1 Overview
6.9.2 Others: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Coagulation Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 South & Central America Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Clinical Laboratory Analyzers
7.3.1 Overview
7.3.2 Clinical Laboratory Analyzers: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 South & Central America Coagulation Market, by Clinical Laboratory Analyzers
7.4 Point-of-Care Testing Analyzers
7.4.1 Overview
7.4.2 Point-of-Care Testing Analyzers: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Coagulation Market – Revenue and Forecast to 2030 – by Offering
8.1 Overview
8.2 South & Central America Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
8.3 Diagnosis
8.3.1 Overview
8.3.2 Diagnosis: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 South & Central America Coagulation Market, by Diagnosis
8.4 Treatment
8.4.1 Overview
8.4.2 Treatment: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 South & Central America Coagulation Market, by Treatment
9. South & Central America Coagulation Market – Revenue and Forecast to 2030 – by Technology
9.1 Overview
9.2 South & Central America Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
9.3 Optical Technology
9.3.1 Overview
9.3.2 Optical Technology: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Mechanical Technology
9.4.1 Overview
9.4.2 Mechanical Technology: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Electrochemical Technology
9.5.1 Overview
9.5.2 Electrochemical Technology: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Coagulation Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 South & Central America Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Clinical Laboratories
10.3.1 Overview
10.3.2 Clinical Laboratories: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals
10.4.1 Overview
10.4.2 Hospitals: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11. South & Central America Coagulation Market – Country Analysis
11.1 South & Central America Coagulation Market, Revenue and Forecast to 2030
11.1.1 South & Central America Coagulation Market by Country
11.1.1.1 Brazil
11.1.1.1.1 Overview
11.1.1.1.2 Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.1.3 Brazil Coagulation Market, by Disease Indication
11.1.1.1.4 Brazil Coagulation Market, by Type
11.1.1.1.4.1 Brazil Coagulation Market, by Clinical Laboratory Analyzer
11.1.1.1.5 Brazil Coagulation Market, by Offering
11.1.1.1.5.1 Brazil Coagulation Market, by Diagnosis
11.1.1.1.5.2 Brazil Coagulation Market, by Treatment
11.1.1.1.6 Brazil Coagulation Market, by Technology
11.1.1.1.7 Brazil Coagulation Market, by End User
11.1.1.2 Argentina
11.1.1.2.1 Overview
11.1.1.2.2 Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.2.3 Argentina Coagulation Market, by Disease Indication
11.1.1.2.4 Argentina Coagulation Market, by Type
11.1.1.2.4.1 Argentina Coagulation Market, by Clinical Laboratory Analyzer
11.1.1.2.5 Argentina Coagulation Market, by Offering
11.1.1.2.5.1 Argentina Coagulation Market, by Diagnosis
11.1.1.2.5.2 Argentina Coagulation Market, by Treatment
11.1.1.2.6 Argentina Coagulation Market, by Technology
11.1.1.2.7 Argentina Coagulation Market, by End User
11.1.1.3 Rest of South & Central America
11.1.1.3.1 Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.3.2 Rest of South & Central America Coagulation Market, by Disease Indication
11.1.1.3.3 Rest of South & Central America Coagulation Market, by Type
11.1.1.3.3.1 Rest of South & Central America Coagulation Market, by Clinical Laboratory Analyzer
11.1.1.3.4 Rest of South & Central America Coagulation Market, by Offering
11.1.1.3.4.1 Rest of South & Central America Coagulation Market, by Diagnosis
11.1.1.3.4.2 Rest of South & Central America Coagulation Market, by Treatment
11.1.1.3.5 Rest of South & Central America Coagulation Market, by Technology
11.1.1.3.6 Rest of South & Central America Coagulation Market, by End User
12. Coagulation Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Coagulation Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Siemens Healthineers AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Şti.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sysmex Corp
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Genrui Biotech Co., Ltd.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Transasia Bio-Medicals Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Horiba Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
LIST OF TABLES
Table 1. South & Central America Coagulation Market Segmentation
Table 2. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 3. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 4. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 5. Optical Technologies and Their Applications
Table 6. Mechanical Technologies and Their Applications
Table 7. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 8. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 9. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 10. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 11. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 12. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 13. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 14. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 15. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 16. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 17. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 18. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 19. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 20. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 21. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 22. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 23. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 24. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 25. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 26. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 27. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 28. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 29. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 30. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 31. Recent Inorganic Growth Strategies in the Coagulation Market
Table 32. Recent Organic Growth Strategies in the Coagulation Market
Table 33. Glossary of Terms, Coagulation Market
LIST OF FIGURES
Figure 1. South & Central America Coagulation Market Segmentation, By Country
Figure 2. South & Central America Coagulation Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Coagulation Market Revenue (US$ million), 2020 – 2030
Figure 5. South & Central America Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 6. Vitamin K Deficiency: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liver Disease: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Development of Circulating Anticoagulant: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hemophilia: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Von Willebrand’s Disease: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. South & Central America Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
Figure 14. Clinical Laboratory Analyzers: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Point-of-Care Testing Analyzers: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. South & Central America Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
Figure 17. Diagnosis: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Treatment: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 20. Optical Technology: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mechanical Technology: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Electrochemical Technology: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. South & Central America Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 25. Clinical Laboratories: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Hospitals: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Coagulation Market, By Country, 2022 (US$ million)
Figure 29. South & Central America Coagulation Market, By Key Countries, 2022 and 2030 (%)
Figure 30. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 31. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 32. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 33. Growth Strategies in the Coagulation Market
The List of Companies – South & Central America Coagulation Market
1. F. Hoffmann-La Roche Ltd
2. Genrui Biotech Co., Ltd
3. Horiba Ltd.
4. ImproGen Diagnostik Kimya San. & Tic. Ltd.Şti.
5. Siemens Healthineers AG
6. Sysmex Corp
7. Transasia Bio-Medicals Ltd
You must be logged in to post a review.
Reviews
There are no reviews yet.